M
Mizuho Latest Price Targets & Analyst Ratings
# | Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
---|---|---|---|---|---|---|---|---|
251 |
251
Kura Oncology
KURA
$713M
|
MG
Mara Goldstein
| $8.22 | $30 |
265%
upside
| Outperform | 3 months ago |
|
252 |
252
Globant
GLOB
$2.78B
|
DD
Dan Dolev
| $63.12 | $153 |
142%
upside
| Outperform | 3 months ago |
|
253 |
253
PG&E
PCG
$33.2B
|
AC
Anthony Crowdell
| $15.09 | $21 |
39%
upside
| Outperform | 3 months ago |
|
254 |
254
Alibaba
BABA
$323B
|
JL
James Lee
| $135.58 | $160 |
18%
upside
| Outperform | 3 months ago |
|
255 |
255
Rivian
RIVN
$17.2B
|
VR
Vijay Rakesh
| $14.21 | $13 |
9%
downside
| Neutral | 3 months ago |
|
256 |
256
General Motors
GM
$55.5B
|
VR
Vijay Rakesh
| $58.27 | $58 |
0%
downside
| Outperform | 3 months ago |
|
257 |
257
Autoliv
ALV
$9.58B
|
VR
Vijay Rakesh
| $124.69 | $112 |
10%
downside
| Outperform | 3 months ago |
|
258 |
258
Doximity
DOCS
$13B
|
SV
Steven Valiquette
| $69.34 | $60 |
13%
downside
| Neutral | 3 months ago |
|
259 |
259
EyePoint Pharmaceuticals
EYPT
$966M
|
GS
Graig Suvannavejh
| $14.01 | $26 |
86%
upside
| Outperform | 3 months ago |
|
260 |
260
Honeywell
HON
$136B
|
BL
Brett Linzey
| $214.25 | $250 |
17%
upside
| Outperform | 3 months ago |
|
261 |
261
UGI
UGI
$7.43B
|
GM
Gabriel Moreen
| $34.57 | $39 |
13%
upside
| Outperform | 3 months ago |
|
262 |
262
New Jersey Resources
NJR
$4.72B
|
GM
Gabriel Moreen
| $47.05 | $50 |
6%
upside
| Neutral | 3 months ago |
|
263 |
TECX
263
Tectonic Therapeutic, Inc. Common Stock
TECX
$314M
|
UE
Uy Ear
| $16.80 | $85 |
406%
upside
| Outperform | 3 months ago |
|
264 |
264
Harmony Biosciences
HRMY
$2.07B
|
GS
Graig Suvannavejh
| $35.99 | $48 |
33%
upside
| Outperform | 3 months ago |
|
265 |
265
Rubrik
RBRK
$17.6B
|
GM
Gregg Moskowitz
| $90.93 | $86 |
5%
downside
| Neutral | 3 months ago |
|
266 |
266
JD.com
JD
$44.6B
|
JL
James Lee
| $31.45 | $48 |
53%
upside
| Outperform | 3 months ago |
|
267 |
267
Apellis Pharmaceuticals
APLS
$3.55B
|
GS
Graig Suvannavejh
| $28.13 | $20 |
29%
downside
| Neutral | 3 months ago |
|
268 |
268
Amylyx Pharmaceuticals
AMLX
$910M
|
GS
Graig Suvannavejh
| $10.20 | $8 |
22%
downside
| Outperform | 3 months ago |
|
269 |
269
Gulfport Energy Corp
GPOR
$3.08B
|
NK
Nitin Kumar
| $175.14 | $226 |
29%
upside
| Neutral | 3 months ago |
|
270 |
270
Comstock Resources
CRK
$4.66B
|
NK
Nitin Kumar
| $15.90 | $24 |
51%
upside
| Neutral | 3 months ago |
|
271 |
271
CNX Resources
CNX
$4.18B
|
NK
Nitin Kumar
| $29.55 | $36 |
22%
upside
| Underperform | 3 months ago |
|
272 |
272
Vital Energy
VTLE
$635M
|
NK
Nitin Kumar
| $16.40 | $23 |
40%
upside
| Neutral | 3 months ago |
|
273 |
273
Matador Resources
MTDR
$6.01B
|
WJ
William Janela
| $48.24 | $73 |
51%
upside
| Outperform | 3 months ago |
|
274 |
274
Crescent Energy
CRGY
$2.23B
|
WJ
William Janela
| $8.76 | $12 |
37%
upside
| Neutral | 3 months ago |
|
275 |
275
Civitas Resources
CIVI
$3.19B
|
WJ
William Janela
| $34.39 | $52 |
51%
upside
| Outperform | 3 months ago |
|